Top 3D Printed Surgical Models Companies

3D Printed Surgical Models Market size was valued at USD 600.68 Million in 2023 and is poised to grow from USD 690.78 Million in 2024 to USD 2113.11 Million by 2032, growing at a CAGR of 15% during the forecast period (2025-2032).

The global 3D printed surgical models market is highly competitive and fragmented, with the presence of several key players. These players are actively engaged in expanding their businesses through various strategies, such as mergers and acquisitions, partnerships, collaborations, and product launches. The intense competition among these players has led to a high degree of innovation and the introduction of new and advanced products in the market. Additionally, the players are also focused on expanding their global presence through strategic partnerships and collaborations with local players. As the demand for 3D printed surgical models continues to increase, it is expected that the competition among the players in the market will intensify further. 'Stratasys Ltd. (Israel)', '3D Systems Corporation (US)', 'Materialise NV (Belgium)', 'Renishaw plc (UK)', 'EOS GmbH (Germany)', 'EnvisionTEC GmbH (Germany)', 'SLM Solutions Group AG (Germany)', 'Organovo Holdings, Inc. (US)', 'Formlabs, Inc. (US)', 'Concept Laser GmbH (Germany)', '3D LifePrints (UK)', 'Axial3D (UK)', 'RS Print (Spain)', 'Anatomiz3D Medtech Private Limited (India)', 'Replica 3DM (Australia)', 'Osteo3d (US)', 'Youbionic (Italy)', 'ProX DMP 300 (US)', 'Cyfuse Biomedical K.K. (Japan)', 'Bio3D Technologies Pte Ltd. (Singapore)'

The 3D printed surgical models provide surgeons with the opportunity to create personalized models that mimic the patient's anatomy, allowing for more precise surgical planning and reduced surgical time. This helps in improving surgical outcomes and reducing the risk of complications. For instance, in April 2021, Stratasys Ltd. collaborated with Materialize NV to develop personalized surgical models for pediatric heart surgery. This collaboration aims to reduce surgical time, improve outcomes, and enhance patient care.

Rising adoption of 3D printed surgical models in neurosurgery: The use of 3D printed surgical models is rapidly gaining traction in neurosurgery due to the complexity of the surgical procedures and the need for precise anatomical models. In May 2021, Oxford Performance Materials, Inc. received FDA clearance for its 3D printed spinal implant, which was developed using a patient-specific anatomical model.

North America currently dominates the global 3D-printed surgical model market, and it is expected to continue growing at a CAGR of 15.8% over the forecast period. This high market share can be attributed to factors such as an increasing geriatric population, high adoption of advanced technology, strong government initiatives for quality healthcare, and supportive reimbursement policies in the U.S. and Canada. Furthermore, high investments in research and development have led to increased adoption of surgical models manufactured using 3D printing, which further boosts market growth. The presence of dominant 3D printer companies with a robust distribution network in the U.S. and Canada, involved in R&D to introduce innovative technologies to the 3D-printed surgical model market, also contributes to the region's market growth.